Vitranu
Company

Vitranu

Biotechnology 7720 Rivers Edge Dr 5 employees
Employees
5
Contacts
2
Emails
2
Phones
2

Vitranu Overview

Headquarters
7720 Rivers Edge Dr
Website
www.vitranu.com
Industry
Biotechnology
Employees
5
Founded
2020
Funding
1.5M

About Vitranu

Vitranu is developing a Tunable Extended Release Capsule (TERC™) for sustained delivery of therapeutics to the eye via intravitreal injection. TERC™ is manufactured with biodegradable polymers using novel electrospinning technology to produce a double-walled, tunable capsule that can be filled with unaltered biologic or small molecule therapeutics. By modifying the electrospinning process parameters, capsules can be made with defined pore sizes and "tuned" to deliver the payload with the desired drug elution profile. This patented and unique approach provides a platform technology to fulfill the unmet need of sustained, controllable ophthalmic drug delivery.

Vitranu Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
2
50.0% coverage

Vitranu Org Chart

Sample employees and titles
Name Title Contact
Katelyn Swindle-Reilly Associate Professor and Innovation
View
Robin Sears Chairman of the Board of Directors
View
Gary Charbonneau SVP, Gm and Head of Research and Early
Email Phone
John W. Black Medtech Executive & Sales Leadership
Email Phone

Employees by Management Level

Individual contributor 2 profiles
VP / Head 1 profile
Associate / junior 1 profile

Compare Similar Companies to Vitranu